AVALIAÇÃO MICROBIOLÓGICA E CARACTERIZAÇÃO DE SUSPENSÕES CONTENDO NANOCÁPSULAS DE SULFADIAZINA DE PRATA

Detalhes bibliográficos
Ano de defesa: 2010
Autor(a) principal: Agarrayua, Danielle Araujo
Orientador(a): Hoelzel, Solange Cristina da Silva Martins
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Franciscana
Programa de Pós-Graduação: Mestrado Acadêmico em Nanociências
Departamento: Biociências e Nanomateriais
País: BR
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/275
http://www.tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/285
Resumo: Silver sulfadiazine (SDAg), the drug of choice for topical treatment of infected burns, possesses a broad spectrum of action and the incidence of resistance is considerably lower than with most antibiotics. In the presence of water SDAg undergoes a partial hydrolysis with formation of free sulfadiazine and silver, which has been previously shown to be photoreactive. This work presents as main objective evaluated the microbiological activity of SDAg associated with nanocapsules prepared from poly(-caprolactone), using capric and caprylic acid triglycerides and butyleneglicol cocoate as oily phase. The suspensions were prepared by interfacial deposition of pre-formed polymer and were characterized in term of SDAg contents, associated drug within the nanoparticles, pH, mean size of particles and zeta potentials of nanocapsules with SDAg, and evaluated the influence of the types of oils (capric and caprylic acid triglycerides and butyleneglicol cocoato) on nanocapsules physico-chemical caracterization. The microbial activity of SDAg nanocapsules were analyzed against microorganism Pseudomonas aeruginosa (ATCC 27853) by the method of agar diffusion. The dosage technique of SDAg in HPLC was validated in all analyzed parameters and the results obtained met the specifications for linearity, precision, and accuracy. The suspension containing capric and caprylic acid triglycerides presented average size of 225 nm (±1,71), zeta potential of 26 mV (±1,09) and pH values of 5,6. This sample showed an 100 % of drug entrapment. The values size particle of the suspension containing butyleneglicol cocoato was 221,4 nm (±2,3), zeta potential of 27,9 mV (±1,7) and pH 5,7. Suspension with miglyol® SDAg contents were 77 % and 97,96%, determined by HPLC and microbiological assay, respectively, being higher when compared with suspension butyleneglicol cocoato, 38,5 % e 87,26 % demonstrating that the extraction of SDAg used is more efficient for the nanocapsules suspension with capric and caprylic acid triglycerides as oil core. Through the results, it is possible to conclude that the silver sulfadiazine nanocapsule suspensions are an alternative for the corporation in topical formulations.